Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Manufacturing

Our API manufacturing facilities are operated in accordance with cGMP (ICH Q7) and are regularly inspected/audited by international regulatory authorities and numerous customers. We have eight commercial USFDA inspected production units, from which six production units are in India, and one in Mexico and the UK.

India

  • 6 manufacturing units
  • Manufacturing capabilities include HPAPI, oncology, and other synthetic molecules

Mexico

  • Located in Cuernavaca
  • Steroid manufacturing capabilities

United Kingdom

  • Located in Mirfield
  • Manufacturing capabilities include Prostaglandins and PEGylation

 

Our API manufacturing plants are complemented by formulation manufacturing facilities which can supply a variety of different dosage forms.